GPT Healthcare (NSE:GPTHEALTH) Is Paying Out A Dividend Of ₹1.50

GPT Healthcare Limited (NSE:GPTHEALTH) has announced that it will pay a dividend of ₹1.50 per share on the 4th of September. The dividend yield will be 1.6% based on this payment which is still above the industry average.

Advertisement

GPT Healthcare's Payment Could Potentially Have Solid Earnings Coverage

While it is great to have a strong dividend yield, we should also consider whether the payment is sustainable. Prior to this announcement, GPT Healthcare's dividend was only 41% of earnings, however it was paying out 117% of free cash flows. While the company may be more focused on returning cash to shareholders than growing the business at this time, we think that a cash payout ratio this high might expose the dividend to being cut if the business ran into some challenges.

Over the next year, EPS is forecast to expand by 97.4%. If the dividend continues along recent trends, we estimate the payout ratio will be 19%, which is in the range that makes us comfortable with the sustainability of the dividend.

historic-dividend
NSEI:GPTHEALTH Historic Dividend July 8th 2025

Check out our latest analysis for GPT Healthcare

GPT Healthcare Doesn't Have A Long Payment History

It is tough to make a judgement on how stable a dividend is when the company hasn't been paying one for very long. This doesn't mean that the company can't pay a good dividend, but just that we want to wait until it can prove itself.

The Dividend Looks Likely To Grow

The company's investors will be pleased to have been receiving dividend income for some time. It's encouraging to see that GPT Healthcare has been growing its earnings per share at 35% a year over the past five years. GPT Healthcare is clearly able to grow rapidly while still returning cash to shareholders, positioning it to become a strong dividend payer in the future.

In Summary

In summary, while it's good to see that the dividend hasn't been cut, we are a bit cautious about GPT Healthcare's payments, as there could be some issues with sustaining them into the future. While the low payout ratio is a redeeming feature, this is offset by the minimal cash to cover the payments. Overall, we don't think this company has the makings of a good income stock.

It's important to note that companies having a consistent dividend policy will generate greater investor confidence than those having an erratic one. At the same time, there are other factors our readers should be conscious of before pouring capital into a stock. As an example, we've identified 1 warning sign for GPT Healthcare that you should be aware of before investing. Is GPT Healthcare not quite the opportunity you were looking for? Why not check out our selection of top dividend stocks.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NSEI:GPTHEALTH

GPT Healthcare

Owns and operates a chain of multispecialty hospitals under the ILS Hospitals brand name in India.

Undervalued with high growth potential and pays a dividend.

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7057.7% undervalued
10 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
HE
HedgeY
ASTS logo
HedgeY on AST SpaceMobile ·

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

Fair Value:US$17036.9% undervalued
33 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative
FU
ONTO logo
FundamentalFlow on Onto Innovation ·

Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Fair Value:US$38027.7% undervalued
23 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7446.7% undervalued
55 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative

Updated Narratives

CA
Cashflow_Queen
RR. logo
Cashflow_Queen on Rolls-Royce Holdings ·

A company I wrote off that quietly turned itself around

Fair Value:UK£14.019.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MA
TTD logo
matttttt on Trade Desk ·

Wait and see

Fair Value:US$29.2428.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
QU
QuanD
COIN logo
QuanD on Coinbase Global ·

Coinbase is your leverage on Crypto

Fair Value:US$247.3933.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9721.8% undervalued
56 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7446.7% undervalued
55 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1932.0% undervalued
47 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative